These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12879130)

  • 1. Cyclooxygenase enzymes as targets for therapeutic intervention in inflammation.
    Colville-Nash PR; Gilroy DW
    Drug News Perspect; 2000 Dec; 13(10):587-97. PubMed ID: 12879130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation.
    Colville-Nash PR; Gilroy DW
    BioDrugs; 2001; 15(1):1-9. PubMed ID: 11437671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal antiinflammatory drugs and their effects.
    Simon LS
    J Clin Rheumatol; 1996 Jun; 2(3):135-40. PubMed ID: 19078048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of antiinflammatory drugs.
    Vane JR; Botting RM
    Int J Tissue React; 1998; 20(1):3-15. PubMed ID: 9561441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease.
    Willoughby DA; Moore AR; Colville-Nash PR
    Lancet; 2000 Feb; 355(9204):646-8. PubMed ID: 10696997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the role of COX 2 in inflammation.
    Gilroy DW; Colville-Nash PR
    J Mol Med (Berl); 2000; 78(3):121-9. PubMed ID: 10868474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors.
    Kulkarni SK; Jain NK; Singh A
    Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):291-8. PubMed ID: 11031730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific cyclooxygenase-2 inhibitors. Basis and options of a pharmacotherapeutic concept].
    Hinz B; Brune K
    Anaesthesist; 2000 Nov; 49(11):964-71. PubMed ID: 11151817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal antiinflammatory agents.
    Botting JH
    Drugs Today (Barc); 1999; 35(4-5):225-35. PubMed ID: 12973428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems.
    Sharma S; Sharma SC
    Indian J Exp Biol; 1997 Oct; 35(10):1025-31. PubMed ID: 9475035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediation of inflammation by cyclooxygenase-2.
    Seibert K; Masferrer J; Zhang Y; Gregory S; Olson G; Hauser S; Leahy K; Perkins W; Isakson P
    Agents Actions Suppl; 1995; 46():41-50. PubMed ID: 7610990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal sparing anti-inflammatory drugs--effects on ulcerogenic and healing responses.
    Takeuchi K; Tanaka A; Suzuki K; Mizoguchi H
    Curr Pharm Des; 2001 Jan; 7(1):49-69. PubMed ID: 11172701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective inhibitors of cyclooxygenase-2 (COX-2), celecoxib and parecoxib: a systematic review].
    Mateos JL
    Drugs Today (Barc); 2010 Feb; 46 Suppl A():1-25. PubMed ID: 20224826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2--10 years later.
    Hinz B; Brune K
    J Pharmacol Exp Ther; 2002 Feb; 300(2):367-75. PubMed ID: 11805193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of aspirin-like drugs.
    Vane JR; Botting RM
    Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):2-10. PubMed ID: 9219313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer.
    Raz A
    Biochem Pharmacol; 2002 Feb; 63(3):343-7. PubMed ID: 11853685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of COX-2-selective inhibitors.
    Brater DC; Harris C; Redfern JS; Gertz BJ
    Am J Nephrol; 2001; 21(1):1-15. PubMed ID: 11275626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 selective inhibitors.
    Cannon GW
    Drugs Today (Barc); 1999 Jul; 35(7):487-96. PubMed ID: 12973394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.